J8700 HCPCS Level II code: Temozolomide, oral, 5 mg
J8700 is the HCPCS code for “Temozolomide, oral, 5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J8700Temozolomide, oral, 5 mg
Short description: Temozolomide
HCPCS · United States
Medicare details
The indicators CMS publishes with J8700 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2001
Where J8700 sits
- 1J codesDrugs administered other than orally
- 2Active code J8700Temozolomide, oral, 5 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J8700 mean?
J8700 is the HCPCS code for “Temozolomide, oral, 5 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J8700?
CMS lists J8700’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J8700
All J codesJ8610Methotrexate; oral, 2.5 mgJ8611Methotrexate (jylamvo), oral, 2.5 mgJ8612Methotrexate (xatmep), oral, 2.5 mgJ8650Nabilone, oral, 1 mgJ8655Netupitant 300 mg and palonosetron 0.5 mg, oralJ8670Rolapitant, oral, 1 mgJ8705Topotecan, oral, 0.25 mgJ8999Prescription drug, oral, chemotherapeutic, nosJ9000Injection, doxorubicin hydrochloride, 10 mgJ9003Leuprolide injectable (camcevi etm), 1 mgJ9010Injection, alemtuzumab, 10 mgJ9011Injection, datopotamab deruxtecan-dlnk, 1 mg